Date Title Document
Valeant Pharmaceuticals Completes Syndication of Incremental Term Loans Date 12/23/11 Title Valeant Pharmaceuticals Completes Syndication of Incremental Term Loans Download PDF
Valeant Pharmaceuticals Completes Acquisition of iNova Date 12/22/11 Title Valeant Pharmaceuticals Completes Acquisition of iNova Download PDF
Valeant Pharmaceuticals to Hold Conference Call to Announce 2012 Financial Guidance Date 12/22/11 Title Valeant Pharmaceuticals to Hold Conference Call to Announce 2012 Financial Guidance Download PDF
Valeant Pharmaceuticals Completes Acquisition of Dermik Date 12/19/11 Title Valeant Pharmaceuticals Completes Acquisition of Dermik Download PDF
Valeant Pharmaceuticals Proposes to Acquire ISTA Pharmaceuticals Inc. for $6.50 Per Share in Cash Date 12/16/11 Title Valeant Pharmaceuticals Proposes to Acquire ISTA Pharmaceuticals Inc. for $6.50 Per Share in Cash Download PDF
Valeant Announces Successful Results From Phase III Onychomycosis Trials Date 12/16/11 Title Valeant Announces Successful Results From Phase III Onychomycosis Trials Download PDF
Valeant Announces the Completion of the Privatization of Afexa Life Sciences Inc. Date 12/12/11 Title Valeant Announces the Completion of the Privatization of Afexa Life Sciences Inc. Download PDF
Valeant Pharmaceuticals Receives Approval From FTC in Connection With Acquisition of Ortho Dermatologics and Dermik Date 12/12/11 Title Valeant Pharmaceuticals Receives Approval From FTC in Connection With Acquisition of Ortho Dermatologics and Dermik Download PDF
Valeant Pharmaceuticals to Syndicate Incremental Term Loans Date 11/30/11 Title Valeant Pharmaceuticals to Syndicate Incremental Term Loans Download PDF
Valeant Pharmaceuticals Agrees to Acquire iNova Date 11/20/11 Title Valeant Pharmaceuticals Agrees to Acquire iNova Download PDF
Valeant Pharmaceuticals Appoints Howard B. Schiller as Chief Financial Officer Date 11/10/11 Title Valeant Pharmaceuticals Appoints Howard B. Schiller as Chief Financial Officer Download PDF
Valeant Pharmaceuticals Reports 2011 Third Quarter Financial Results Date 11/03/11 Title Valeant Pharmaceuticals Reports 2011 Third Quarter Financial Results Download PDF
Valeant Announces New $1.5 Billion Securities Repurchase Program Date 11/03/11 Title Valeant Announces New $1.5 Billion Securities Repurchase Program Download PDF
Valeant Announces Take-Up of Additional Afexa Shares and Special Meeting of Shareholders of Afexa to Approve Its Privatization Date 10/27/11 Title Valeant Announces Take-Up of Additional Afexa Shares and Special Meeting of Shareholders of Afexa to Approve Its Privatization Download PDF
Valeant Pharmaceuticals to Announce 2011 Third Quarter Results on November 3, 2011 Date 10/21/11 Title Valeant Pharmaceuticals to Announce 2011 Third Quarter Results on November 3, 2011 Download PDF
Valeant Pharmaceuticals Successfully Completes Refinancing of Senior Secured Credit Facilities Date 10/21/11 Title Valeant Pharmaceuticals Successfully Completes Refinancing of Senior Secured Credit Facilities Download PDF
Valeant Announces Results of Friendly Offer for Afexa Life Sciences Inc. Date 10/18/11 Title Valeant Announces Results of Friendly Offer for Afexa Life Sciences Inc. Download PDF
Valeant Announces That Afexa Supports and Recommends Valeant's Increased Offer and Agrees to Certain Amendments to Support Agreement Date 09/30/11 Title Valeant Announces That Afexa Supports and Recommends Valeant's Increased Offer and Agrees to Certain Amendments to Support Agreement Download PDF
Valeant Pharmaceuticals Announces Approval Of Colesevelam Hydrochloride In Canada Date 09/28/11 Title Valeant Pharmaceuticals Announces Approval Of Colesevelam Hydrochloride In Canada Download PDF
Valeant Pharmaceuticals to Refinance Senior Secured Credit Facilities Date 09/26/11 Title Valeant Pharmaceuticals to Refinance Senior Secured Credit Facilities Download PDF
Valeant Pharmaceuticals Intends to Raise Offer for Afexa Life Sciences Inc. to $0.85 per Share Date 09/26/11 Title Valeant Pharmaceuticals Intends to Raise Offer for Afexa Life Sciences Inc. to $0.85 per Share Download PDF
Valeant Pharmaceuticals Announces Second Request from the Federal Trade Commission in Connection with Pending Dermatology Acquisitions Date 09/20/11 Title Valeant Pharmaceuticals Announces Second Request from the Federal Trade Commission in Connection with Pending Dermatology Acquisitions Download PDF
Valeant Pharmaceuticals Announces Mailing of Offer and Take-Over Bid Circular to Shareholders of Afexa Date 09/09/11 Title Valeant Pharmaceuticals Announces Mailing of Offer and Take-Over Bid Circular to Shareholders of Afexa Download PDF
Valeant Pharmaceuticals to Present at Industry Conferences Date 09/02/11 Title Valeant Pharmaceuticals to Present at Industry Conferences Download PDF
Valeant Pharmaceuticals Announces All-Cash Offer to Acquire Afexa Life Sciences Inc. Date 08/30/11 Title Valeant Pharmaceuticals Announces All-Cash Offer to Acquire Afexa Life Sciences Inc. Download PDF
Valeant Pharmaceuticals Announces Increase to Monetary Limit Under Its Securities Repurchase Program Date 08/29/11 Title Valeant Pharmaceuticals Announces Increase to Monetary Limit Under Its Securities Repurchase Program Download PDF
Valeant Pharmaceuticals Files a Notice of Intention to Make a Normal Course Issuer Bid Date 08/23/11 Title Valeant Pharmaceuticals Files a Notice of Intention to Make a Normal Course Issuer Bid Download PDF
Valeant Pharmaceuticals Completes Acquisition of Sanitas Group Date 08/19/11 Title Valeant Pharmaceuticals Completes Acquisition of Sanitas Group Download PDF
Valeant Pharmaceuticals Announces Resignation of Michael Van Every From Valeant's Board of Directors Date 08/18/11 Title Valeant Pharmaceuticals Announces Resignation of Michael Van Every From Valeant's Board of Directors Download PDF
Valeant Pharmaceuticals Reports 2011 Second Quarter Financial Results Date 08/04/11 Title Valeant Pharmaceuticals Reports 2011 Second Quarter Financial Results Download PDF
Valeant Pharmaceuticals Appoints Ronald Farmer to Fill Board Vacancy Date 08/03/11 Title Valeant Pharmaceuticals Appoints Ronald Farmer to Fill Board Vacancy Download PDF
Valeant Pharmaceuticals International, Inc. Date 08/03/11 Title Valeant Pharmaceuticals International, Inc. Download PDF
Valeant Pharmaceuticals Announces Approval of Sublinox® in Canada Date 07/25/11 Title Valeant Pharmaceuticals Announces Approval of Sublinox® in Canada Download PDF
Valeant Pharmaceuticals to Announce 2011 Second Quarter Results on August 4, 2011 Date 07/20/11 Title Valeant Pharmaceuticals to Announce 2011 Second Quarter Results on August 4, 2011 Download PDF
Valeant Pharmaceuticals Announces Distribution Agreement for Zuacta(TM) in Canada Date 07/19/11 Title Valeant Pharmaceuticals Announces Distribution Agreement for Zuacta(TM) in Canada Download PDF
Valeant Pharmaceuticals Agrees to Acquire Ortho Dermatologics Date 07/15/11 Title Valeant Pharmaceuticals Agrees to Acquire Ortho Dermatologics Download PDF
Valeant Pharmaceuticals Agrees to Acquire Dermik Date 07/11/11 Title Valeant Pharmaceuticals Agrees to Acquire Dermik Download PDF
Valeant Pharmaceuticals Announces License Agreement With Meda for North American Rights for Elidel® and Xerese(TM) Date 06/30/11 Title Valeant Pharmaceuticals Announces License Agreement With Meda for North American Rights for Elidel® and Xerese(TM) Download PDF
Valeant and GlaxoSmithKline Announce U.S. FDA Approval of Potiga(TM) (ezogabine) Date 06/13/11 Title Valeant and GlaxoSmithKline Announce U.S. FDA Approval of Potiga(TM) (ezogabine) Download PDF
Valeant Pharmaceuticals Agrees to Acquire Sanitas Group for Approximately EUR314 Million in Cash Date 05/24/11 Title Valeant Pharmaceuticals Agrees to Acquire Sanitas Group for Approximately EUR314 Million in Cash Download PDF
Kinerase® Introduces "Change Your Skin, Change Your Life" Charity Campaign Date 05/16/11 Title Kinerase® Introduces "Change Your Skin, Change Your Life" Charity Campaign Download PDF
Valeant Pharmaceuticals to Webcast 2011 Annual Meeting of Shareholders Date 05/11/11 Title Valeant Pharmaceuticals to Webcast 2011 Annual Meeting of Shareholders Download PDF
Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results Date 05/09/11 Title Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results Download PDF
Valeant Pharmaceuticals Congratulates Teva and Cephalon on Their Transaction Date 05/02/11 Title Valeant Pharmaceuticals Congratulates Teva and Cephalon on Their Transaction Download PDF
Valeant Pharmaceuticals to Announce 2011 First Quarter Results on May 9, 2011 Date 04/29/11 Title Valeant Pharmaceuticals to Announce 2011 First Quarter Results on May 9, 2011 Download PDF
Valeant Pharmaceuticals Announces Letter to Cephalon Stockholders Date 04/21/11 Title Valeant Pharmaceuticals Announces Letter to Cephalon Stockholders Download PDF
Valeant Pharmaceuticals Responds to Cephalon Board's Letter Date 04/21/11 Title Valeant Pharmaceuticals Responds to Cephalon Board's Letter Download PDF
Valeant Pharmaceuticals Announces Redemption of 4.0% Convertible Subordinated Notes Due 2013 Date 04/20/11 Title Valeant Pharmaceuticals Announces Redemption of 4.0% Convertible Subordinated Notes Due 2013 Download PDF
Regulatory Update - GSK and Valeant Respond to FDA on ezogabine Date 04/18/11 Title Regulatory Update - GSK and Valeant Respond to FDA on ezogabine Download PDF
Valeant Pharmaceuticals Adds Corporate Governance Expert Abe Friedman to its Slate of Proposed Cephalon Directors Date 04/18/11 Title Valeant Pharmaceuticals Adds Corporate Governance Expert Abe Friedman to its Slate of Proposed Cephalon Directors Download PDF
Valeant Pharmaceuticals Files Presentation for Cephalon Stockholders Date 04/11/11 Title Valeant Pharmaceuticals Files Presentation for Cephalon Stockholders Download PDF
Meda to License Elidel to Valeant Pharmaceuticals Date 04/07/11 Title Meda to License Elidel to Valeant Pharmaceuticals Download PDF
Valeant Pharmaceuticals Files Preliminary Consent Solicitation Statement With the SEC Date 04/05/11 Title Valeant Pharmaceuticals Files Preliminary Consent Solicitation Statement With the SEC Download PDF
Promius Pharma and Valeant Form Collaboration to Market Cloderm(R) Cream in the United States Date 04/01/11 Title Promius Pharma and Valeant Form Collaboration to Market Cloderm(R) Cream in the United States Download PDF
Valeant Pharmaceuticals Proposes to Acquire Cephalon, Inc. for $73 Per Share in Cash Date 03/29/11 Title Valeant Pharmaceuticals Proposes to Acquire Cephalon, Inc. for $73 Per Share in Cash Download PDF
GSK and Valeant Receive European Authorisation for Trobalt (retigabine) Date 03/29/11 Title GSK and Valeant Receive European Authorisation for Trobalt (retigabine) Download PDF
Valeant Pharmaceuticals Extends Contract with J. Michael Pearson as CEO and Appoints Him as Chairman of the Board Date 03/22/11 Title Valeant Pharmaceuticals Extends Contract with J. Michael Pearson as CEO and Appoints Him as Chairman of the Board Download PDF
Valeant Pharmaceuticals Completes Acquisition of PharmaSwiss S.A. Date 03/11/11 Title Valeant Pharmaceuticals Completes Acquisition of PharmaSwiss S.A. Download PDF
Valeant Announces Pricing of Senior Notes Date 03/03/11 Title Valeant Announces Pricing of Senior Notes Download PDF
Valeant Launches Senior Notes Offering Date 03/01/11 Title Valeant Launches Senior Notes Offering Download PDF
Valeant Pharmaceuticals Reports 2010 Fourth Quarter Financial Results Date 02/24/11 Title Valeant Pharmaceuticals Reports 2010 Fourth Quarter Financial Results Download PDF
Valeant Pharmaceuticals to Present at RBC Capital Markets' 2011 Healthcare Conference Date 02/16/11 Title Valeant Pharmaceuticals to Present at RBC Capital Markets' 2011 Healthcare Conference Download PDF
Valeant Pharmaceuticals to Announce 2010 Fourth Quarter and Full Year Results on February 24, 2011 Date 02/15/11 Title Valeant Pharmaceuticals to Announce 2010 Fourth Quarter and Full Year Results on February 24, 2011 Download PDF
Valeant Pharmaceuticals Announces Acquisition of Cholestagel(R) in Canada Date 02/10/11 Title Valeant Pharmaceuticals Announces Acquisition of Cholestagel(R) in Canada Download PDF
Valeant Pharmaceuticals Announces License Of ACZONE(R) (dapsone) Gel 5% In Canada Date 02/08/11 Title Valeant Pharmaceuticals Announces License Of ACZONE(R) (dapsone) Gel 5% In Canada Download PDF
Valeant Launches Senior Notes Offering Date 02/03/11 Title Valeant Launches Senior Notes Offering Download PDF
Valeant Announces Pricing of Senior Notes Date 02/03/11 Title Valeant Announces Pricing of Senior Notes Download PDF
Valeant Pharmaceuticals to Acquire U.S. and Canadian Rights to Zovirax(R) Date 02/03/11 Title Valeant Pharmaceuticals to Acquire U.S. and Canadian Rights to Zovirax(R) Download PDF
Valeant Pharmaceuticals to Acquire PharmaSwiss S.A. Date 02/01/11 Title Valeant Pharmaceuticals to Acquire PharmaSwiss S.A. Download PDF
Regulatory Update - GSK and Valeant Receive Positive Opinion in Europe From the CHMP for Trobalt (Retigabine) Date 01/21/11 Title Regulatory Update - GSK and Valeant Receive Positive Opinion in Europe From the CHMP for Trobalt (Retigabine) Download PDF
Valeant Pharmaceuticals to Present at J.P. Morgan 29th Annual Health Care Conference Date 01/10/11 Title Valeant Pharmaceuticals to Present at J.P. Morgan 29th Annual Health Care Conference Download PDF
Annual Report

2015 Annual Report

The right products
The right philosophy.
record organic growth.

View All